drugset / Trial / NCT00621491
Prevention of Venous Thrombosis After Permanent Transvenous Leads Implantation
Completed
101 enrolled
University of Sao Paulo
Conselho Nacional de Desenvolvimento Científico e Tecnológico · collabFundação de Amparo à Pesquisa do Estado de São Paulo · collab
RandomizedParallel-groupTriple-blindPrevention
Summary
The aim of this study was to compare the safety and efficacy of warfarin versus placebo, administered for 6 months, in the prevention of thromboembolic complications after transvenous cardiac devices implantation in high-risk patients.
Timeline
- Start
- 2004-02
- Primary completion
- 2007-09
- Completion
- 2008-07
Publications
- Results Costa R, Da Silva KR, Rached R, Martinelli Filho M, Carnevale FC, Moreira LF, Stolf NA. Prevention of venous thrombosis by warfarin after permanent transvenous leads implantation in high-risk patients. Pacing Clin Electrophysiol. 2009 Mar;32 Suppl 1:S247-51. doi: 10.1111/j.1540-8159.2008.02295.x.
- Results Silva KR, Costa R, Abi Rached R, Martinelli Filho M, Caldas JG, Carnevale FC, Moreira LF, Stolf NA. Warfarin prevents venous obstruction after cardiac devices implantation in high-risk patients: partial analysis. Rev Bras Cir Cardiovasc. 2008 Oct-Dec;23(4):542-9. doi: 10.1590/s0102-76382008000400015. English, Portuguese.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Warfarin | Small molecule | 5 mg | Oral |